1 Radiology Center, Kyungpook National University Medical Center, Daegu, Republic of Korea.
AJR Am J Roentgenol. 2014 Jun;202(6):1238-44. doi: 10.2214/AJR.13.11311.
The purpose of this study was to investigate the diagnostic performance of MRI in stratifying tumors stage III (T3) in patients with rectal cancer by measuring the extramural depth of tumor invasion based on the Radiologic Society of North America (RSNA) proposal and to validate its role as a prognostic indicator.
From January 2006 to July 2009, 146 patients with surgically and pathologically confirmed T3 rectal adenocarcinoma who underwent preoperative MRI were enrolled. Two blinded radiologists measured the maximum extramural depth of tumor invasion on T2-weighted images. To evaluate the diagnostic performance of MRI for stratifying subgroups, the study population was assigned into three subgroups (T3a, T3b, and T3c) according to extramural depth of tumor invasion (< 5, 5-10, and > 10 mm).To validate the role of extramural depth of tumor invasion as a prognostic indicator, Cox regression analysis was used for estimation of independent risk factors for postoperative recurrence. Three-year recurrence-free survival was evaluated by the Kaplan-Meier method with a log-rank test. Histopathologic reports were used as the reference standard.
The overall accuracy of MRI for stratifying subgroups was 71.2% (104/146) and 77.4% (113/146) for reviewers 1 and 2. Extramural depth of tumor invasion was an independent risk factor for 3-year recurrence-free survival (hazard ratio, 2.186; 95% CI, 1.336-3.577; p = 0.002). Kaplan-Meier curves revealed a significant difference in 3-year recurrence-free survival rates for each subgroup (86%, 69%, and 43% for T3a, T3b, and T3c; p < 0.03).
MRI can be used for prognostic stratification according to extramural depth of tumor invasion based on the RSNA proposal for patients with T3 rectal cancer.
本研究旨在通过测量基于放射学协会北美(RSNA)建议的肿瘤外侵深度,评估 MRI 在直肠癌患者 T3 期肿瘤分期中的诊断性能,并验证其作为预后指标的作用。
本研究共纳入 2006 年 1 月至 2009 年 7 月期间 146 例经手术和病理证实为 T3 直肠腺癌的患者,所有患者均行术前 MRI 检查。两名盲法阅片医生在 T2 加权图像上测量肿瘤最大外侵深度。为了评估 MRI 对分层分组的诊断性能,将研究人群根据肿瘤外侵深度(<5、5-10 和>10mm)分为三组(T3a、T3b 和 T3c)。采用 Cox 回归分析对术后复发的独立危险因素进行评估,以验证肿瘤外侵深度作为预后指标的作用。采用 Kaplan-Meier 法和对数秩检验评估 3 年无复发生存率。组织病理学报告被用作参考标准。
MRI 对分层分组的总体准确性为 71.2%(104/146)和 77.4%(113/146),两位阅片医生的结果一致。肿瘤外侵深度是 3 年无复发生存的独立危险因素(危险比,2.186;95%可信区间,1.336-3.577;p=0.002)。Kaplan-Meier 曲线显示,各亚组 3 年无复发生存率差异有统计学意义(T3a、T3b 和 T3c 亚组的 3 年无复发生存率分别为 86%、69%和 43%;p<0.03)。
基于 RSNA 建议,MRI 可用于 T3 直肠癌患者的肿瘤外侵深度预测,为预后分层提供依据。